POLR3A variants in hereditary spastic paraparesis and ataxia: clinical, genetic, and neuroradiological findings in a cohort of Italian patients.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 26 03 2021
accepted: 03 07 2021
pubmed: 24 7 2021
medline: 28 1 2022
entrez: 23 7 2021
Statut: ppublish

Résumé

Mutations in POLR3A are characterized by high phenotypic heterogeneity, with manifestations ranging from severe childhood-onset hypomyelinating leukodystrophic syndromes to milder and later-onset gait disorders with central hypomyelination, with or without additional non-neurological signs. Recently, a milder phenotype consisting of late-onset spastic ataxia without hypomyelinating leukodystrophy has been suggested to be specific to the intronic c.1909 + 22G > A mutation in POLR3A. Here, we present 10 patients from 8 unrelated families with POLR3A-related late-onset spastic ataxia, all harboring the c.1909 + 22G > A variant. Most of them showed an ataxic-spastic picture, two a "pure" cerebellar phenotype, and one a "pure" spastic presentation. The non-neurological findings typically associated with POLR3A mutations were absent in all the patients. The main findings on brain MRI were bilateral hyperintensity along the superior cerebellar peduncles on FLAIR sequences, observed in most of the patients, and cerebellar and/or spinal cord atrophy, found in half of the patients. Only one patient exhibited central hypomyelination. The POLR3A mutations present in this cohort were the c.1909 + 22G > A splice site variant found in compound heterozygosity with six additional variants (three missense, two nonsense, one splice) and, in one patient, with a novel large deletion involving exons 14-18. Interestingly, this patient had the most "complex" presentation among those observed in our cohort; it included some neurological and non-neurological features, such as seizures, neurosensory deafness, and lipomas, that have not previously been reported in association with late-onset POLR3A-related disorders, and therefore further expand the phenotype.

Identifiants

pubmed: 34296356
doi: 10.1007/s10072-021-05462-1
pii: 10.1007/s10072-021-05462-1
pmc: PMC8789690
doi:

Substances chimiques

POLR3A protein, human EC 2.7.7.6
RNA Polymerase III EC 2.7.7.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1071-1077

Informations de copyright

© 2021. The Author(s).

Références

Wolf NI, Vanderver A, van Spaendonk RM et al (2014) Clinical spectrum of 4H leukodystrophy caused by POLR3A and POLR3B mutations. Neurology 83(21):1898–18905
doi: 10.1212/WNL.0000000000001002
Azmanov DN, Siira SJ, Chamova T et al (2016) Transcriptome-wide effects of a POLR3A gene mutation in patients with an unusual phenotype of striatal involvement. Hum Mol Genet 25(19):4302–4314
doi: 10.1093/hmg/ddw263
Di Bella D, Magri S, Benzoni C et al (2021) Hypomyelinating leukodystrophies in adults: Clinical and genetic features. Eur J Neurol 28(3):934–944
doi: 10.1111/ene.14646
Harting I, Al-Saady M, Krägeloh-Mann I et al (2020) POLR3A variants with striatal involvement and extrapyramidal movement disorder. Neurogenetics 21(2):121–133
doi: 10.1007/s10048-019-00602-4
Temel SG, Ergoren MC, Manara E et al (2020) Unique combination and in silico modeling of biallelic POLR3A variants as a cause of Wiedemann-Rautenstrauch syndrome. Eur J Hum Genet 28(12):1675–1680
doi: 10.1038/s41431-020-0673-1
Zanette V, Reyes A, Johnson M et al (2020) Neurodevelopmental regression, severe generalized dystonia, and metabolic acidosis caused by POLR3A mutations. Neurol Genet 6(6):e521
doi: 10.1212/NXG.0000000000000521
Minnerop M, Kurzwelly D, Wagner H et al (2017) Hypomorphic mutations in POLR3A are a frequent cause of sporadic and recessive spastic ataxia. Brain 140(6):1561–1578
doi: 10.1093/brain/awx095
Gauquelin L, Tétreault M, Thiffault I et al (2018) POLR3A variants in hereditary spastic paraplegia and ataxia. Brain 141(1):e1
doi: 10.1093/brain/awx290
Minnerop M, Kurzwelly D, Rattay TW et al (2018) Reply: POLR3A variants in hereditary spastic paraplegia and ataxia. Brain 141(1):e2
doi: 10.1093/brain/awx291
Minnerop M, Kurzwelly D, Wagner H, Schüle R, Ramirez A (2019) Reply: biallelic POLR3A variants confirmed as a frequent cause of hereditary ataxia and spastic paraparesis. Brain 142(4):e13
doi: 10.1093/brain/awz042
Rydning SL, Koht J, Sheng Y et al (2019) Biallelic POLR3A variants confirmed as a frequent cause of hereditary ataxia and spastic paraparesis. Brain 142(4):e12
doi: 10.1093/brain/awz041
Infante J, Serrano-Cárdenas KM, Corral-Juan M et al (2020) POLR3A-related spastic ataxia: new mutations and a look into the phenotype. J Neurol 267(2):324–330
doi: 10.1007/s00415-019-09574-9
Morales-Rosado JA, Macke EL, Cousin MA et al (2020) Interpretation challenges of novel dual-class missense and splice-impacting variant in POLR3A-related late-onset hereditary spastic ataxia. Mol Genet Genomic Med 8(9):e1341
pubmed: 32597037 pmcid: 7507001
Riso V, Galatolo D, Barghigiani M et al (2021) A next generation sequencing-based analysis of a large cohort of ataxic patients refines the clinical spectrum associated with spinocerebellar ataxia 21. Eur J Neurol. https://doi.org/10.1111/ene.14868
doi: 10.1111/ene.14868 pubmed: 34710286 pmcid: 8361921
Chrestian N, Dupré N, Gan-Or Z et al (2016) Clinical and genetic study of hereditary spastic paraplegia in Canada. Neurol Genet 3(1):e122
doi: 10.1212/NXG.0000000000000122
Lieto M, Riso V, Galatolo D et al (2020) The complex phenotype of spinocerebellar ataxia type 48 in eight unrelated Italian families. Eur J Neurol 27(3):498–505
doi: 10.1111/ene.14094
Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M (2019) CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 47(D1):D886–D894
doi: 10.1093/nar/gky1016
Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424
doi: 10.1038/gim.2015.30
Ruggiero L, Iovino A, Dubbioso R et al (2020) Multimodal evaluation of an Italian family with a hereditary spastic paraplegia and POLR3A mutations. Ann Clin Transl Neurol 7(11):2326–2331
doi: 10.1002/acn3.51221
Gutierrez M, Thiffault I, Guerrero K et al (2015) Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy. Orphanet J Rare Dis 10:69
doi: 10.1186/s13023-015-0279-9

Auteurs

Ilaria Di Donato (I)

Department of Medicine, Surgery and Neurosciences, University of Siena, viale Bracci, 16, 50055, Siena, Italy. didonatoila@gmail.com.

Antonio Gallo (A)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Ivana Ricca (I)

Molecular Medicine and Neurogenetics, IRCCS Fondazione Stella Maris, via dei Giacinti 2, Calambrone, 56128, Pisa, Italy.

Nicola Fini (N)

Neurology Unit, Department of Neurosciences, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.

Gabriella Silvestri (G)

Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, UOC Neurologia, Rome, Italy.
Department of Neurosciences, Università Cattolica del Sacro Cuore, Rome, Italy.

Fiorella Gurrieri (F)

Medical Genetics, Università Campus Bio-Medico, 00128, Rome, Italy.

Mario Cirillo (M)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Alfonso Cerase (A)

Department of Medicine, Surgery and Neurosciences, University of Siena, viale Bracci, 16, 50055, Siena, Italy.

Gemma Natale (G)

Molecular Medicine and Neurogenetics, IRCCS Fondazione Stella Maris, via dei Giacinti 2, Calambrone, 56128, Pisa, Italy.

Federica Matrone (F)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.

Vittorio Riso (V)

Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, UOC Neurologia, Rome, Italy.
Department of Neurosciences, Università Cattolica del Sacro Cuore, Rome, Italy.

Mariarosa Anna Beatrice Melone (MAB)

Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, PA, USA.

Alessandra Tessa (A)

Molecular Medicine and Neurogenetics, IRCCS Fondazione Stella Maris, via dei Giacinti 2, Calambrone, 56128, Pisa, Italy.

Giovanna De Michele (G)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.

Antonio Federico (A)

Department of Medicine, Surgery and Neurosciences, University of Siena, viale Bracci, 16, 50055, Siena, Italy.

Alessandro Filla (A)

Department of Neurosciences, Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy.

Maria Teresa Dotti (MT)

Department of Medicine, Surgery and Neurosciences, University of Siena, viale Bracci, 16, 50055, Siena, Italy.

Filippo Maria Santorelli (FM)

Molecular Medicine and Neurogenetics, IRCCS Fondazione Stella Maris, via dei Giacinti 2, Calambrone, 56128, Pisa, Italy. filippo3364@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH